what is glp 1 receptor Glucagon-like peptide-1 (GLP-1) agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and #obesity. GLP-1 receptor agonists and GLP-1 and glucose-dependent insulinotropic PDB-101: Molecule of the Month:
Description
The fact that multiple independent review sites rate it in the 3-3.5 range out of 5 places it squarely in the "adequate" category, not the "excellent" one
17 , e13762 (2024)
The retrospective cohort study, GLP-1 Receptor Agonist Use and Weight Change in Patients With Breast Cancer, published in the August 2025 edition of Oncology , 3 was based on data from 116 patients with a breast cancer diagnosis prescribed GLP-1 RAs at the Memorial Sloan Kettering Cancer Center, from 2015 to 2023
Quick Answer: GLP-1 medications may help reduce joint pain primarily through significant weight loss that decreases mechanical stress on weight-bearing joints, though they are not FDA-approved for this purpose
The cardiovascular and renal protective benefits observed with certain GLP-1 medications also diminish after discontinuation
And is great with communication
